(Q27144071)
Statements
754.202±0 dalton
1 reference
Magnescope (TN) (English)
7 October 2016
C₂₃H₄₂GdN₅O₁₃
1 reference
Magnescope (TN) (English)
20 November 2016
CNCC(C(C(C(CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
1 reference
Magnescope (TN) (English)
20 November 2016
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
1 reference
Magnescope (TN) (English)
20 November 2016
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
1 reference
Identifiers
1 reference
Magnescope (TN) (English)
20 November 2016
2 references
Magnescope (TN) (English)
20 November 2016
2 references
gadoterate meglumine (English)
20 November 2016
1 reference
Gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-D-glucitol (1:1:1) (English)
20 November 2016
1 reference
[2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl-kappa~4~N~1~,N~4~,N~7~,N~10~)tetraacetato(3-)]gadolinium - 1-deoxy-1-(methylamino)-D-glucitol (1:1) (English)
20 November 2016
1 reference
Magnescope (TN) (English)
20 November 2016
1 reference
28 October 2019
Gadoterate meglumine (English)
10 May 2021
1 reference
1 reference
gadoterate meglumine (English)
20 November 2016
1 reference
gadoterate meglumine (English)
20 November 2016
1 reference
gadoterate meglumine (English)
20 November 2016
1 reference
gadoterate meglumine (English)
20 November 2016
1 reference